Please login to the form below
NICE backs two cancer drugs
Boehringer’s Giotrif and Janssen’s Velcade given final go-ahead for NHS use
Pfizer set to file Xeljanz for psoriasis
Set to add another indication after positive study results
Valeant offers $45.7bn for Botox firm Allergan
Trend for major pharma deals continues
Pfizer rumoured to be after AstraZeneca
Is this the return of the pharma mega-merger?
Novartis pays $16bn for GSK's oncology portfolio
Swiss company strikes series of deals, including one to step away from vaccines
EMA warns on stolen Herceptin
Says vials of cancer drug have been tampered with and re-introduced into supply chain
Lilly's stomach cancer drug cleared by FDA
Cyramza is tipped to reach blockbuster status depending on approvals
GSK corruption claims extend to Jordan and Lebanon
Follows bribery allegations in Poland, China and Iraq
Reckitt Benckiser may spin out pharma division
Moves to focus on consumer health and household goods
Sex is a good trick
But pharma companies - and payers - should stop incestuous ‘best practice’ behaviours and look for new ways of comparing options
-
Tuberculosis: treatment and preventionOne of the most significant global diseases, effective new TB therapies are sorely needed
-
This month in 1917: A tale of two MercksUS enters World War I severing ties between Merck & Co and its German parent
-
Boehringer lines up biosimilars of major drugsProspects include copies of Humira, Avastin and MabThera
-
Unicheck recognised for innovationWins a Red Herring Top 100 Europe Award for anti-counterfeiting platform
-
Genzyme backs first International Pompe DayRaises awareness of rare neuromuscular disease
-
NICE gives partial backing to Ferring's prostate cancer drugFirmagon on course for use on NHS in England and Wales
-
BioAlliance and Topotarget merge to focus on rare cancersFrench and Danish firms combine to develop orphan oncology drugs
-
Sanofi takes to Twitter to support Spanish pharmacy portalSays new account on the social network will help support community pharmacists
-
Menarini launches urology campaign in GreecePE information push includes Not Just A Moment website
Latest appointments
-
Merck Serono CEO joins L’Oreal boardBelén Garijo named independent director at beauty company
-
Spectrum appoints Dr Dalna Harvey as regulatory project managerShe brings experience gained at firms such as Parexel, Chiron and Wyeth
-
Ogilvy HealthPR appoints social media managerRebecca Canvin joins from Brandcast Media/ Health
-
Polyhedra appoints Steve Hobbs chief business development officerHe joins the group from Apodi
-
Hall & Partners boosts senior health teamAppoints Jeanette Hodgson and promotes Marie Bennett
Featured jobs
- Brand Manager GI Cancers
- On application
- Senior Account Manager- Med Comms, London
- Competitive Salary Offered
- Editorial Lead - Oxfordshire
- Negotiable
- Senior Account Executive- Med Coms, London
- Competitive Salary Offered
Subscribe to our email news alerts
PMHub
PAN
PAN specialises in original, enticing, aspirational and engaging digital and print solutions to maximize brand potential (www.influentialcreativity.com) `Influential creativity' is...
Latest intelligence
- Study highlights value of internet for doctors in Eastern Europe
- Electronic direct mail is proving popular as online access increases...
- England’s clinical commissioning landscape
- Who are the real masters in the new NHS?...
- How will the new landscape of Hep C treatments affect patients?
- The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Quick links
